Chembond Material Technologies Limited · NSE:CHEMBOND

Chembond Material Technologies — Q1 FY27 Earnings Presentation

10 slides from Chembond Material Technologies's earnings presentation, Sep 1, 2026

  1. Slide 1: Chembond Material Technologies Limited FY27 Q1 Financial Report

    Chembond Material Technologies Limited FY27 Q1 Financial Report

  2. Slide 2: Good Revenue Growth; Margins Suffer

    Good Revenue Growth; Margins Suffer Material Technologies and Animal Health remained strong; input cost inflation and pricing lag affected product margins REVENUE EBITDA PBT ₹72.42 Cr ₹6.74 Cr ₹5.83 Cr +25.6% Q1FY26 | +0.9% Q4 FY26 +10.1% Q1FY26 | +28.3% Q4FY26 +8.7% Q1FY26 | +34.5% Q4 FY26 Business

  3. Slide 3: Revenue growth was broad-based, with Material Technologies leading the expansion

    Revenue growth was broad-based, with Material Technologies leading the expansion Q1 revenue by business segment ₹ lakhs | Q1 FY26 vs Q1 FY27 What changed Material Technologies 6,128 +27.5% vs Q1 FY26 4,806 ₹48.1 Cr → ₹61.3 Cr Animal Health +15.9% vs Q1 FY26 962 1,114 ₹9.6 Cr → ₹11.1 Cr Material Tech

  4. Slide 4: Revenue mix by business

    Revenue mix by business Share of consolidated revenue | Q1 FY26 vs Q1 FY27 Portfolio readout Material Technologies 84.6% of Q1 FY27 revenue Q1 FY27 84.6% 15.4% Animal Health 15.4% Q1 FY26 83.3% 16.7% of Q1 FY27 revenue 0% 20% 40% 60% 80% 100% KEY TAKEAWAY Mix remains broadly consistent year-on-year

  5. Slide 5: Quarterly revenue momentum- Material Technologies

    Quarterly revenue momentum- Material Technologies ₹ crore Momentum dashboard 70 Material Technologies 59.84 61.28 60 ₹61.3 Cr 51.86 48.06 47.69 50 43.59 43.58 +2.4% vs Q4FY26 42.43 38.89 40 Highest quarterly revenue in the period 30 20 10 0 Q1 FY25 Q2 FY25 Q3 FY25 Q4 FY25 Q1 FY26 Q2 FY26 Q3 FY26 Q4

  6. Slide 6: Quarterly revenue momentum- Animal Health

    Quarterly revenue momentum- Animal Health ₹ crore Momentum dashboard Animal Health 14 11.91 ₹11.1 Cr 12 11.04 11.14 9.62 10.07 +15.9% vs Q1FY26 10 9.46 8.63 7.38 7.35 Q1 moderation vs Q4, while QoQ growth 8 remains strong 6 4 2 0 Q1 FY25 Q2 FY25 Q3 FY25 Q4 FY25 Q1 FY26 Q2 FY26 Q3 FY26 Q4 FY26 Q1 FY2

  7. Slide 7: Quarterly EBITDA- Consolidated

    Quarterly EBITDA- Consolidated Q1 FY26 Q4 FY26 Q1 FY27 ₹6.12 Cr ₹5.25 Cr ₹6.74 Cr Material Technologies 9.00 ₹4.55 Cr 7.93 8.00 6.74 7.00 6.12 6.00 5.53 5.32 5.25 Animal Health 5.00 4.15 3.96 3.90 ₹1.28 Cr 4.00 3.00 2.00 1.00 - Q1 FY25 Q2 FY25 Q3 FY25 Q4 FY25 Q1 FY26 Q2 FY26 Q3 FY26 Q4 FY26 Q1 FY27

  8. Slide 8: 5 Year Financial Performance – Consolidated

    5 Year Financial Performance – Consolidated 2023-24 Highlights 2025-26 2024-25 Resta ted 2022-23 2021-22 Operating Result Revenue From Operations 25,007.40 20,129.99 17,824.43 44,044.41 34,898.08 Other Income 266.94 761.68 1,405.74 463.61 861.08 Finance Cost 36.69 63.79 76.03 104.13 68.91 Depreciati

  9. Slide 9: 5 Year Financial Performance – Standalone

    5 Year Financial Performance – Standalone 2023-24 Highlights 2025-26 2024-25 Re state d 2022-23 2021-22 Opera ting Result Revenue From Operations 21,014.12 17,120.70 15,334.04 5,086.45 4,563.92 Other Income 266.41 719.97 1,405.08 541.34 1,010.51 Finance Cost 11.91 9.05 24.72 6.48 4.82 Depreciation 3

  10. Slide 10: Thank You

    Thank You www.chembond.in [email protected] Chembond Material Technologies Ltd. (formerly known as Chembond Chemicals Limited) EL-71 MIDC Mahape Navi Mumbai 400710. INDIA T: +91 22 62643000 - 03 F: +91 22 27681294

Chembond Material Technologies — Q1 FY27 Earnings Presentation on 6ix